Cefaly® 10230

GUDID 05425018850129

The Cefaly® Prevent device is indicated for the prophylactic treatment of episodic migraine in adults.

Cefaly Technology SPRL

Craniofacial analgesia electrical stimulator
Primary Device ID05425018850129
NIH Device Record Keyc64df6ad-231d-4f35-a861-483e1ea48e8d
Commercial Distribution StatusIn Commercial Distribution
Brand NameCefaly®
Version Model NumberPrevent
Catalog Number10230
Company DUNS762450752
Company NameCefaly Technology SPRL
Device Count1
DM Exemptfalse
Pre-market Exemptfalse
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kittrue
Device Combination Productfalse
Single Usefalse
Lot Batchfalse
Serial Numbertrue
Manufacturing Datefalse
Expiration Datetrue
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptiontrue
OTC Over-The-Counterfalse

Customer Support Contacts

Phone(203) 309-5670
Emailinfo@cefaly.us
Phone(203) 309-5670
Emailinfo@cefaly.us

Operating and Storage Conditions

Storage Environment TemperatureBetween 23 Degrees Fahrenheit and 95 Degrees Fahrenheit
Storage Environment HumidityBetween 45 Percent (%) Relative Humidity and 75 Percent (%) Relative Humidity
Storage Environment Atmospheric PressureBetween 50 KiloPascal and 106 KiloPascal
Handling Environment TemperatureBetween 50 Degrees Fahrenheit and 95 Degrees Fahrenheit
Handling Environment HumidityBetween 30 Percent (%) Relative Humidity and 75 Percent (%) Relative Humidity
Handling Environment Atmospheric PressureBetween 70 KiloPascal and 106 KiloPascal
Storage Environment Atmospheric PressureBetween 50 KiloPascal and 106 KiloPascal
Storage Environment HumidityBetween 45 Percent (%) Relative Humidity and 75 Percent (%) Relative Humidity
Storage Environment TemperatureBetween 23 Degrees Fahrenheit and 95 Degrees Fahrenheit
Handling Environment TemperatureBetween 50 Degrees Fahrenheit and 95 Degrees Fahrenheit
Handling Environment HumidityBetween 30 Percent (%) Relative Humidity and 75 Percent (%) Relative Humidity
Handling Environment Atmospheric PressureBetween 70 KiloPascal and 106 KiloPascal

Device Identifiers

Device Issuing AgencyDevice ID
GS105425018850129 [Previous]
GS105425018850266 [Primary]

FDA Pre-market Approvals/Notifications & deNovo

FDA Product Code

PCCStimulator, Nerve, Electrical, Transcutaneous, For Migraine

Sterilization

Steralize Prior To Usefalse
Device Is Sterilefalse

Device Entry Metadata

Public Version StatusUpdate
Device Record StatusPublished
Public Version Number4
Public Version Date2019-03-11
Device Publish Date2017-11-29

On-Brand Devices [Cefaly®]

05425018850129The Cefaly® Prevent device is indicated for the prophylactic treatment of episodic migraine in
05425018850259The Cefaly® Dual device is indicated for: - The acute treatment of migraine with or without aur
05425018850242The Cefaly® Acute device is indicated for the acute treatment of migraine with or without aura
05425018850150Kit 3 Electrodes Blue Gel for Cefaly II
05425018850143Kit 3 electrodes for Cefaly II
05425018850105Kit 3 electrodes Blue Gel for Cefaly I
05425018850044Kit 3 electrodes for Cefaly I
05425018850273Cefaly DUAL Enhanced is a newer version of Cefaly DUAL which is an FDA - cleared device Indicat
05425018850181Hypoallergenic Electrode CEFALY Enhanced Kit (3 electrodes)
05425018850174CEFALY Enhanced Electrode Kit .3 electrodes

Trademark Results [Cefaly]

Mark Image

Registration | Serial
Company
Trademark
Application Date
CEFALY
CEFALY
87924056 not registered Live/Pending
CEFALY Technology
2018-05-16
CEFALY
CEFALY
79053734 3647710 Live/Registered
CEFALY Technology
2008-04-28

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.